
CareDx, Inc CDNA
$ 22.75
3.64%
Quarterly report 2026-Q1
added 04-28-2026
CareDx, Inc Shares 2011-2026 | CDNA
Annual Shares CareDx, Inc
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 53.3 M | 52.8 M | 53.8 M | 53.3 M | 52.2 M | 46.5 M | 42.2 M | 35.6 M | 23.3 M | 16.5 M | 11.9 M | 5.82 M | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 53.8 M | 5.82 M | 37.3 M |
Quarterly Shares CareDx, Inc
| 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 51.2 M | 50.9 M | 52.5 M | 54.3 M | 55.3 M | 54.8 M | 52.9 M | 52.2 M | 51.7 M | 51.5 M | 54.2 M | 53.8 M | 53.6 M | 53.5 M | 53.5 M | 53.2 M | 53 M | 52.9 M | 52.7 M | 52.2 M | 51.2 M | 49.4 M | 49 M | 44.7 M | 42.8 M | 42.5 M | 42.4 M | 42.1 M | 41.6 M | 40.1 M | 37.2 M | 35.5 M | 29.6 M | 28 M | 22.5 M | 21.4 M | 21.3 M | 21.3 M | 19.1 M | 13.6 M | 12 M | 11.9 M | 11.9 M | 11.8 M | 11.8 M | 11.8 M | 9.28 M | 1.01 M | 1.01 M | 1.01 M | 1.01 M | 1.01 M | 1.01 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 55.3 M | 1.01 M | 34.8 M |
Shares of other stocks in the Diagnostics research industry
| Issuer | Shares | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
50.9 K | - | -8.98 % | $ 14.8 K | ||
|
Centogene N.V.
CNTG
|
20.9 M | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
10.3 M | - | - | $ 1.31 B | ||
|
Celcuity
CELC
|
46.8 M | $ 92.59 | 5.9 % | $ 4.33 B | ||
|
Akumin
AKU
|
89.5 M | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
1.33 M | $ 4.5 | -10.89 % | $ 5.99 M | ||
|
Fulgent Genetics
FLGT
|
30.8 M | $ 18.5 | 1.04 % | $ 569 M | ||
|
Castle Biosciences
CSTL
|
29 M | $ 21.08 | 4.77 % | $ 611 M | ||
|
Aspira Women's Health
AWH
|
34.1 M | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
23.3 M | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
17 M | - | -13.05 % | $ 7.29 M | ||
|
ICON Public Limited Company
ICLR
|
78.4 M | $ 151.82 | -0.28 % | $ 11.9 B | ||
|
Illumina
ILMN
|
155 M | $ 160.03 | 1.26 % | $ 24.8 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
26.6 M | - | - | $ 562 M | ||
|
Guardant Health
GH
|
125 M | $ 130.12 | 4.19 % | $ 16.3 B | ||
|
Chembio Diagnostics
CEMI
|
32.3 M | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
6.23 M | - | - | $ 9.42 M | ||
|
Interpace Biosciences
IDXG
|
4.42 M | $ 1.74 | 3.57 % | $ 7.7 M | ||
|
HTG Molecular Diagnostics
HTGM
|
889 K | - | -20.0 % | $ 1.06 M | ||
|
Global Cord Blood Corporation
CO
|
122 M | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
74.3 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
132 M | - | - | $ 7.1 B | ||
|
NeoGenomics
NEO
|
128 M | $ 11.44 | 4.47 % | $ 1.47 B | ||
|
Genetron Holdings Limited
GTH
|
464 M | - | 0.12 % | $ 80.1 M | ||
|
National Research Corporation
NRC
|
22.4 M | $ 19.75 | 2.17 % | $ 442 M | ||
|
DermTech
DMTK
|
32.6 M | - | -11.32 % | $ 2.94 M | ||
|
Lantheus Holdings
LNTH
|
67.5 M | $ 99.98 | -0.03 % | $ 6.75 B | ||
|
Charles River Laboratories International
CRL
|
49.6 M | $ 189.85 | 1.83 % | $ 9.41 B | ||
|
Pacific Biosciences of California
PACB
|
300 M | $ 1.37 | -0.72 % | $ 411 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
63.8 M | - | - | $ 10.7 B | ||
|
Medpace Holdings
MEDP
|
28.8 M | $ 466.79 | 1.94 % | $ 13.5 B | ||
|
Exact Sciences Corporation
EXAS
|
189 M | - | - | $ 19.8 B | ||
|
Mettler-Toledo International
MTD
|
20.6 M | $ 1 162.79 | 2.1 % | $ 24 B | ||
|
Myriad Genetics
MYGN
|
92.6 M | $ 4.54 | 3.42 % | $ 420 M | ||
|
Natera
NTRA
|
137 M | $ 222.82 | 4.38 % | $ 30.5 B | ||
|
Personalis
PSNL
|
89.2 M | $ 9.75 | -2.89 % | $ 870 M | ||
|
Koninklijke Philips N.V.
PHG
|
948 M | $ 26.5 | 2.63 % | $ 25.1 B | ||
|
Senseonics Holdings
SENS
|
41.7 M | $ 7.43 | 4.21 % | $ 310 M | ||
|
QIAGEN N.V.
QGEN
|
217 M | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
50.8 M | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
2.3 M | $ 2.05 | -0.92 % | $ 4.71 M | ||
|
Laboratory Corporation of America Holdings
LH
|
83.2 M | $ 271.24 | 3.52 % | $ 22.6 B | ||
|
Twist Bioscience Corporation
TWST
|
59.8 M | $ 70.06 | 0.03 % | $ 4.19 B | ||
|
Thermo Fisher Scientific
TMO
|
377 M | $ 494.07 | 5.23 % | $ 186 B | ||
|
Trinity Biotech plc
TRIB
|
359 M | $ 0.66 | -2.32 % | $ 237 M | ||
|
Motus GI Holdings
MOTS
|
1.55 M | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
217 M | $ 9.29 | 2.43 % | $ 2.01 B | ||
|
Waters Corporation
WAT
|
59.5 M | $ 371.15 | 2.15 % | $ 22.1 B | ||
|
Quest Diagnostics Incorporated
DGX
|
111 M | $ 204.53 | 3.71 % | $ 22.7 B |